Condition
Vaginal Microbiota
Total Trials
6
Recruiting
2
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Recruiting2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07715058Not ApplicableCompletedPrimary
Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women
NCT07471373Not ApplicableRecruiting
Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis
NCT05996016Recruiting
Gut and Vaginal Microbiota Profile Study for HIV Women
NCT06486519CompletedPrimary
Collection of Vaginal Microbiota Samples (VAGINOTYPE)
NCT05003505Active Not Recruiting
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection
NCT03346759Phase 4CompletedPrimary
Examining the Impact of Tampon Use on the Vaginal Microbiota
Showing all 6 trials